In the meantime, the regulator has agreed to not take action against compounders of tirzepatide until December 19, unless the agency makes an earlier decision on remand, according to a Leerink investor note issued last month
Originally researched for neurodegenerative conditions, Tesofensine demonstrated a profound impact on body weight and fat mass during clinical trials
severe or persistent upper abdominal pain should prompt urgent medical assessment [10] [11] Dehydration and acute kidney injury (AKI): gastrointestinal fluid losses can lead to dehydration, which may precipitate AKI, particularly in those with pre-existing renal impairment or those taking nephrotoxic medicines Delayed gastric emptying: this may affect the absorption of orally administered medicines, including contraceptive pills and thyroid replacement therapy [11] Injection site reactions: redness, bruising, or discomfort at the subcutaneous injection site Heart rate changes: increases in resting heart rate have been noted with GLP-1 class agents [14] [15] Hypoglycaemia: particularly if used alongside insulin or sulphonylureas Potential pancreatitis risk: a class concern with GLP-1 receptor agonists
After reconstitution, refrigerate at 2-8C and use within 30 days
The relevance of rodent thyroid findings to human physiology remains debated
Then, we teach patients how to give themselves additional shots and are sent home with preloaded syringes to self-inject every other day for two weeks
.webp)
